In this episode, Professor Graham Collins shares with us the highlights in Hodgkin lymphoma from BSH 2025. He takes us through the ECHELON-1 trial, which led to the recent NICE approval of Brentuximab-AVD as a frontline treatment option for advanced stage Hodgkin lymphoma.